Companies: 10,795·Total market cap: $144.5T
Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.

CPH.TOTSXHealthcare● Active
$16.90
+$0.02(+0.12%)
Market Cap$429113332
P/E Ratio
52W High$20.56
52W Low$11.98
Overview

Cipher Pharmaceuticals Inc. (CPH.TO) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CPH.TO · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$7.48M$17.84M$39.83M$28.84M$20.55M
Net Receivables$11.19M$13.86M$5.09M$6.80M$6.66M
Inventory$8.18M$5.79M$2.98M$2.15M$1.65M
Total Current Assets$28.00M$38.48M$48.27M$38.16M$29.33M
PP&E Net$0.57M$0.68M$0.40M$0.48M$0.50M
Goodwill$17.42M$17.45M$15.71M$15.71M$15.71M
Intangible Assets$71.88M$78.75M$1.76M$2.75M$3.65M
Total Assets$156.22M$162.51M$86.03M$73.78M$51.65M
Liabilities
Short-Term Debt$0.29M$0.00M$0.00M$0.00M$0.00M
Accounts Payable$6.38M$5.87M$4.64M$4.11M$5.55M
Total Current Liabilities$25.00M$19.87M$5.25M$9.37M$12.29M
Long-Term Debt$4.99M$40.00M$0.00M$0.00M$0.00M
Total Liabilities$30.20M$60.17M$5.51M$9.70M$12.75M
Stockholders Equity
Retained Earnings$99.93M$77.65M$66.27M$50.52M$25.20M
Total Stockholders Equity$126.01M$102.34M$80.52M$64.08M$38.90M
Total Liab & Equity(computed)$156.22M$162.51M$86.03M$73.78M$51.65M
Debt Summary
Total Debt$5.49M$40.58M$0.35M$0.43M$0.52M
Net Debt($1.98M)$22.74M($39.47M)($28.41M)($20.03M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more Cipher Pharmaceuticals Inc. data

About Cipher Pharmaceuticals Inc. (CPH.TO) Balance Sheet

Cipher Pharmaceuticals Inc. (CPH.TO) balance sheet shows total assets of $0.16B with cash of $0.01B. Total liabilities are $0.03B, total debt $0.01B, and stockholders equity $0.13B.

Frequently asked questions

CPH.TO · 4 questions

Cipher Pharmaceuticals Inc. has total debt of $0.01B with net debt of ($0.00B).

CPH.TO total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10